Trading Day Review: Core Scientific Inc (CORZ) Gains Momentum, Closing at $13.62

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

The price of Core Scientific Inc (NASDAQ: CORZ) closed at $13.62 in the last session, up 0.29% from day before closing price of $13.58. In other words, the price has increased by $0.29 from its previous closing price. On the day, 6.94 million shares were traded. CORZ stock price reached its highest trading level at $13.7 during the session, while it also had its lowest trading level at $13.35.

Ratios:

We take a closer look at CORZ’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Arete on July 22, 2025, initiated with a Buy rating and assigned the stock a target price of $20.

On May 22, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $15.

On January 27, 2025, Keefe Bruyette started tracking the stock assigning a Outperform rating and target price of $22.Keefe Bruyette initiated its Outperform rating on January 27, 2025, with a $22 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when DUCHENE TODD M sold 7,759 shares for $12.39 per share. The transaction valued at 96,142 led to the insider holds 2,049,689 shares of the business.

DUCHENE TODD M bought 7,759 shares of CORZ for $96,142 on Jun 25 ’25. On Jun 06 ’25, another insider, Becker Todd A, who serves as the Former Director of the company, bought 195,687 shares for $12.28 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORZ now has a Market Capitalization of 4159656960 and an Enterprise Value of 4740472320. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.94. Its current Enterprise Value per Revenue stands at 13.605 whereas that against EBITDA is -86.838.

Stock Price History:

The Beta on a monthly basis for CORZ is 6.66, which has changed by 0.46137345 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, CORZ has reached a high of $18.63, while it has fallen to a 52-week low of $6.20. The 50-Day Moving Average of the stock is -3.99%, while the 200-Day Moving Average is calculated to be 10.68%.

Shares Statistics:

According to the various share statistics, CORZ traded on average about 19.14M shares per day over the past 3-months and 11206710 shares per day over the past 10 days. A total of 303.15M shares are outstanding, with a floating share count of 284.98M. Insiders hold about 6.69% of the company’s shares, while institutions hold 89.60% stake in the company. Shares short for CORZ as of 1755216000 were 66347789 with a Short Ratio of 3.47, compared to 1752537600 on 52226477. Therefore, it implies a Short% of Shares Outstanding of 66347789 and a Short% of Float of 21.92.

Earnings Estimates

The stock of Core Scientific Inc (CORZ) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.2, with high estimates of $0.2 and low estimates of $0.2.

Analysts are recommending an EPS of between $0.31 and $0.31 for the fiscal current year, implying an average EPS of $0.31. EPS for the following year is $1.76, with 1.0 analysts recommending between $1.76 and $1.76.

Revenue Estimates

According to 7 analysts, the current quarter’s revenue is expected to be $119.04M. It ranges from a high estimate of $128.28M to a low estimate of $106M. As of the current estimate, Core Scientific Inc’s year-ago sales were $95.35MFor the next quarter, 7 analysts are estimating revenue of $157.89M. There is a high estimate of $179.06M for the next quarter, whereas the lowest estimate is $144.3M.

A total of 7 analysts have provided revenue estimates for CORZ’s current fiscal year. The highest revenue estimate was $445.86M, while the lowest revenue estimate was $409M, resulting in an average revenue estimate of $425.54M. In the same quarter a year ago, actual revenue was $510.67MBased on 16 analysts’ estimates, the company’s revenue will be $877.93M in the next fiscal year. The high estimate is $1.16B and the low estimate is $515.5M.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.